Literature DB >> 6470623

Neutralization of the infectivity of sporozoites of Plasmodium knowlesi by antibodies to a synthetic peptide.

J Gysin, J Barnwell, D H Schlesinger, V Nussenzweig, R S Nussenzweig.   

Abstract

Antibodies against a synthetic peptide representing the repetitive epitope of the circumsporozoite protein (CS) of Plasmodium knowlesi have properties similar to those of antibodies against the native protein. Either antibody reacts with the synthetic peptide, cross-links the CS protein on the membrane of the parasite giving the CSP reaction, and neutralizes the infectivity of sporozoites. The synthetic peptide and sporozoite extracts were equally effective when used in an immunoradiometric assay as antigens to detect antibodies to CS proteins. It is likely that the corresponding synthetic repeats from the human malaria parasites could be used to measure levels of anti-sporozoite antibodies in endemic areas, or to evaluate the humoral response to anti-sporozoite vaccines. The authors are grateful to Dr. Robert Gwadz, NIH, for supplying Anopheles mosquitoes and P. knowlesi sporozoites used in this study.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6470623      PMCID: PMC2187411          DOI: 10.1084/jem.160.3.935

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  10 in total

1.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

Review 2.  Prediction of the secondary structure of proteins from their amino acid sequence.

Authors:  P Y Chou; G D Fasman
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1978

3.  Immunogenic structure of the influenza virus hemagglutinin.

Authors:  N Green; H Alexander; A Olson; S Alexander; T M Shinnick; J G Sutcliffe; R A Lerner
Journal:  Cell       Date:  1982-03       Impact factor: 41.582

4.  Monoclonal antibodies to circumsporozoite proteins identify the species of malaria parasite in infected mosquitoes.

Authors:  F Zavala; R W Gwadz; F H Collins; R S Nussenzweig; V Nussenzweig
Journal:  Nature       Date:  1982-10-21       Impact factor: 49.962

5.  Protective immunity produced by the injection of x-irradiated sporozoites of Plasmodium berghei. V. In vitro effects of immune serum on sporozoites.

Authors:  J Vanderberg; R Nussenzweig; H Most
Journal:  Mil Med       Date:  1969-09       Impact factor: 1.437

6.  Preliminary studies on vaccination of rhesus monkeys with irradiated sporozoites of Plasmodium knowlesi and characterization of surface antigens of these parasites.

Authors:  R W Gwadz; A H Cochrane; V Nussenzweig; R S Nussenzweig
Journal:  Bull World Health Organ       Date:  1979       Impact factor: 9.408

7.  Monoclonal antibodies identify the protective antigens of sporozoites of Plasmodium knowlesi.

Authors:  A H Cochrane; F Santoro; V Nussenzweig; R W Gwadz; R S Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  1982-09       Impact factor: 11.205

8.  ANTIBODIES TO BRADYKININ AND ANGIOTENSIN: A USE OF CARBODIIMIDES IN IMMUNOLOGY.

Authors:  T L GOODFRIEND; L LEVINE; G D FASMAN
Journal:  Science       Date:  1964-06-12       Impact factor: 47.728

9.  Cloning and expression in E. coli of the malarial sporozoite surface antigen gene from Plasmodium knowlesi.

Authors:  J Ellis; L S Ozaki; R W Gwadz; A H Cochrane; V Nussenzweig; R S Nussenzweig; G N Godson
Journal:  Nature       Date:  1983-04-07       Impact factor: 49.962

10.  Circumsporozoite proteins of malaria parasites contain a single immunodominant region with two or more identical epitopes.

Authors:  F Zavala; A H Cochrane; E H Nardin; R S Nussenzweig; V Nussenzweig
Journal:  J Exp Med       Date:  1983-06-01       Impact factor: 14.307

  10 in total
  17 in total

1.  Enhanced epitopic response to a synthetic human malarial peptide by preimmunization with tetanus toxoid carrier.

Authors:  L D Lise; D Mazier; M Jolivet; F Audibert; L Chedid; D Schlesinger
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

Review 2.  Plasmodium falciparum antigens as target molecules for a protective immunization against malaria: an up-to-date review.

Authors:  H G Heidrich
Journal:  Z Parasitenkd       Date:  1986

3.  Induction of biologically active antibodies by a polyvalent synthetic vaccine constructed without carrier.

Authors:  M E Jolivet; F M Audibert; H Gras-Masse; A L Tartar; D H Schlesinger; R Wirtz; L A Chedid
Journal:  Infect Immun       Date:  1987-06       Impact factor: 3.441

Review 4.  Advances and challenges in malaria vaccine development.

Authors:  Peter D Crompton; Susan K Pierce; Louis H Miller
Journal:  J Clin Invest       Date:  2010-12-01       Impact factor: 14.808

5.  Assessment in mice of a synthetic peptide-based vaccine against the sporozoite stage of the human malaria parasite, P. falciparum.

Authors:  H M Etlinger; E P Heimer; A Trzeciak; A M Felix; D Gillessen
Journal:  Immunology       Date:  1988-07       Impact factor: 7.397

6.  Presentation of T-cell epitopes assembled as multiple-antigen peptides to murine and human T lymphocytes.

Authors:  D Grillot; D Valmori; P H Lambert; G Corradin; G Del Giudice
Journal:  Infect Immun       Date:  1993-07       Impact factor: 3.441

7.  Antibodies to pre-erythrocytic Plasmodium falciparum antigens and risk of clinical malaria in Kenyan children.

Authors:  Chandy C John; Aaron J Tande; Ann M Moormann; Peter O Sumba; David E Lanar; Xinan M Min; James W Kazura
Journal:  J Infect Dis       Date:  2008-02-15       Impact factor: 5.226

8.  New approaches for control of infections using synthetic or semi-synthetic constructs containing MDP.

Authors:  L Chedid; F Audibert
Journal:  Springer Semin Immunopathol       Date:  1985

9.  Rabbit and human antibodies to a repeated amino acid sequence of a Plasmodium falciparum antigen, Pf 155, react with the native protein and inhibit merozoite invasion.

Authors:  K Berzins; H Perlmann; B Wåhlin; J Carlsson; M Wahlgren; R Udomsangpetch; A Björkman; M E Patarroyo; P Perlmann
Journal:  Proc Natl Acad Sci U S A       Date:  1986-02       Impact factor: 11.205

Review 10.  Immunological mechanisms underlying protection mediated by RTS,S: a review of the available data.

Authors:  Vasee S Moorthy; W Ripley Ballou
Journal:  Malar J       Date:  2009-12-30       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.